ARCHIVES

New Version Of NCI Proposed IP Agreement Quiets Some Unease At Cooperative Groups; Advisors Urge “No Paralysis” While Awaiting New Language

This article is from The Cancer Letter archive.

Vol. 35 No. 42 | November 13, 2009

Download PDF Visit The Full Archive

Related Articles

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

Funding Opportunities

September 20, 2002

NTP Board Approves Four New Concepts

October 8, 1982